Aligos Therapeutics
Clinical trials sponsored by Aligos Therapeutics, explained in plain language.
Clinical-stage biopharmaceutical company developing antiviral therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hepatitis b drug shows promise in Mid-Stage trial Results expected Mar 2027 (estimated) May already have reported ↗
-
New hepatitis b pill shows promise in early human trial
Disease control CompletedThis early-stage trial tests an experimental oral drug called ALG-000184 in healthy volunteers and people with chronic hepatitis B. The main goals are to check safety, how the body processes the drug, and whether it can lower hepatitis B virus levels. Participants take the drug d…
Phase 1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Kidney patients needed for early COVID drug study
Knowledge-focused CompletedThis early study tests how the experimental COVID-19 drug ALG-097558 moves through the body in people with severe kidney problems compared to healthy volunteers. Twelve adults will take multiple doses of the drug. The goal is to see if kidney function affects drug levels and safe…
Phase 1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New hepatitis b drug studied in Liver-Impaired patients
Knowledge-focused CompletedThis early-stage study tests a single dose of the drug pevifoscorvir sodium in 16 adults: 8 with moderate liver impairment and 8 healthy volunteers. Researchers want to see how the drug is processed in the body and if it is safe. The goal is to gather information for future dosin…
Phase 1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Kidney function may change how hepatitis b drug works
Knowledge-focused CompletedThis early study tests a single dose of the drug pevifoscorvir in 30 people with chronic hepatitis B, some with kidney problems and some with healthy kidneys. Researchers want to see how kidney function affects drug levels and safety. The goal is to learn how to dose the drug pro…
Phase 1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Liver function tested in COVID-19 drug study
Knowledge-focused CompletedThis early-stage study looked at how the experimental drug ALG-097558 behaves in 16 people with moderate liver impairment compared to healthy volunteers. The goal was to measure drug levels and safety, not to treat COVID-19. Results will help guide future dosing for patients with…
Phase 1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC